The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

The FDA has approved the use of nivolumab (Opdivo) with ipilimumab (Yervoy) in adult and pediatric patients age 12 or older ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...

The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the ...

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the treatment of adult and pediatric patients aged 12 years and older with ...

The combination of nivolumab with ipilimumab was approved for unresectable or metastatic microsatellite instability-high (MSI ...

Many other conditions can mimic the symptoms of prostate cancer, both in its early or advanced stages. Here's what you need ...

Liver transplants are becoming a new treatment option for certain colorectal cancer patients whose cancer has spread to their ...

Colorectal cancer is the fourth-most-common cancer in the U.S. and the second deadliest. One in 5 patients is diagnosed with ...